In a 72‑year‑old woman presenting with chronic upper‑thoracic back pain that worsens with movement and deep breathing, height loss of approximately 2 inches, and kyphotic posture, what are the salient clinical features, pertinent risk factors, involved anatomy, recommended physical‑exam maneuvers, appropriate diagnostic studies, the anatomic basis of her signs and symptoms, the most likely diagnosis, and potential complications if left untreated?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 4, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Clinical Impression: Osteoporotic Vertebral Compression Fractures

This 72-year-old woman presents with classic osteoporotic vertebral compression fractures (VCFs), evidenced by chronic thoracic back pain worsening with movement and deep breathing, 2-inch height loss, thoracic kyphosis, and prior calcium/vitamin D supplementation—all hallmark features of progressive osteoporosis with vertebral collapse.


Salient Clinical Features

The case demonstrates multiple pathognomonic findings for osteoporotic VCFs:

  • Chronic thoracic back pain that worsens with movement and deep breathing (Valsalva-like maneuvers)—this pattern is characteristic of vertebral fractures 1
  • Significant height loss (2 inches) over several years—historical height loss >4 cm (>1.5 inches) is a specific indicator for vertebral fractures 2
  • Thoracic kyphosis with forward stooped posture—represents progressive vertebral collapse and spinal deformity
  • Point tenderness over thoracic spine on palpation
  • Previous diagnosis requiring calcium/vitamin D supplementation 5 years ago, suggesting known osteoporosis or osteopenia
  • Age and sex (72-year-old female)—postmenopausal women have the highest risk for osteoporotic fractures

The vital signs are relatively normal, though the respiratory rate of 26/min may reflect splinting from pain with breathing.


Additional History and Risk Factors to Elicit

Critical risk factors to assess:

  • Menopause history: Age at menopause, surgical vs. natural, hormone replacement therapy use
  • Fracture history: Any prior fragility fractures (wrist, hip, spine) or fractures without major trauma 2
  • Medication history:
    • Chronic glucocorticoid use (≥5 mg prednisone equivalent for ≥3 months) 2
    • Thyroid hormone supplementation or excess
    • Aromatase inhibitors, anticonvulsants, proton pump inhibitors
  • Lifestyle factors: Smoking, alcohol consumption (>3 drinks/day), physical inactivity, calcium/vitamin D intake
  • Family history: Maternal hip fracture or osteoporosis
  • Secondary causes:
    • Hyperthyroidism or hyperparathyroidism symptoms
    • Malabsorption (celiac disease, inflammatory bowel disease)
    • Chronic kidney disease
    • Rheumatoid arthritis or other inflammatory conditions
    • Premature ovarian failure
  • Functional impact: Activities of daily living limitations, falls history, balance problems
  • "Red flag" symptoms: Fever, weight loss, night sweats, neurological deficits (suggesting malignancy or infection rather than simple osteoporotic fracture) 3

Gross Anatomy of Involved Structures

Vertebral body anatomy:

  • The thoracic vertebrae (T1-T12) consist of a cylindrical vertebral body anteriorly (weight-bearing structure), pedicles, laminae, and spinous processes posteriorly
  • Vertebral bodies contain trabecular (cancellous) bone internally with a thin cortical shell—trabecular bone is metabolically active and preferentially lost in osteoporosis
  • Intervertebral discs separate adjacent vertebrae, consisting of nucleus pulposus centrally and annulus fibrosus peripherally

In osteoporotic VCFs:

  • Trabecular bone microarchitecture deteriorates, reducing bone mineral density
  • Vertebral bodies collapse, typically in a wedge pattern (anterior > posterior height loss)
  • This creates progressive kyphosis as multiple levels are affected
  • The thoracic spine normally has 20-45° of kyphosis; hyperkyphosis (>45°) increases biomechanical loading 4, 5

Adjacent structures:

  • Spinal cord within the spinal canal (T1-L1/L2 level)
  • Nerve roots exiting through intervertebral foramina
  • Paraspinal muscles (erector spinae, multifidus) that undergo atrophy with chronic pain and immobility
  • Costovertebral joints connecting ribs to thoracic vertebrae
  • Anterior and posterior longitudinal ligaments

Biomechanical consequences:

  • Increased thoracic kyphosis shifts the center of gravity anteriorly
  • This increases compressive loading on anterior vertebral bodies, predisposing to further fractures 4
  • Kyphotic deformity restricts chest wall expansion, impairing pulmonary function

Physical Examination Maneuvers

Beyond the basic examination already performed, conduct:

  • Detailed neurological examination:

    • Lower extremity motor strength (hip flexion, knee extension, ankle dorsiflexion/plantarflexion)
    • Sensory examination in dermatomal distribution
    • Deep tendon reflexes (patellar, Achilles)
    • Pathological reflexes (Babinski sign)
    • Rectal tone and perianal sensation if any concern for cauda equina
  • Spinal examination:

    • Measure actual height and compare to historical height
    • Assess kyphotic angle visually and measure distance from occiput to wall when standing against wall
    • Palpate entire spine for focal tenderness at specific levels
    • Assess for step-offs or deformities
    • Rib-vertebral angle tenderness
  • Functional assessment:

    • Gait evaluation and balance testing
    • Timed Up and Go test
    • Ability to rise from chair without using arms
    • Range of motion of spine (forward flexion, extension, lateral bending)
  • Pulmonary examination:

    • Chest expansion measurement
    • Auscultation for decreased breath sounds (restrictive pattern from kyphosis)
  • Signs of secondary causes:

    • Thyroid examination
    • Cushingoid features
    • Proximal muscle weakness (suggesting osteomalacia or myopathy)

Diagnostic Procedures

Initial imaging (mandatory):

Anteroposterior and lateral thoracic/lumbar spine radiographs should be the first-line imaging 2, 1, 6. Look for:

  • Vertebral height loss (>20% reduction)
  • Wedge deformities (anterior height < posterior height)
  • Biconcave "fish vertebrae" deformities
  • Cortical disruption
  • Number and levels of fractures
  • Degree of kyphosis (Cobb angle measurement)

Vertebral Fracture Assessment (VFA) by DXA can be performed simultaneously with bone density testing 2

MRI of thoracic and lumbar spine is indicated when 2, 6:

  • Radiographs are negative but clinical suspicion remains high
  • Need to differentiate acute from chronic fractures (bone marrow edema on STIR/T2 sequences indicates acute fracture)
  • Neurological deficits are present
  • Concern for malignancy or infection (look for soft tissue masses, epidural involvement, pedicle destruction)
  • Planning vertebral augmentation procedures

Laboratory evaluation (comprehensive panel) 2:

Initial screening:

  • Complete blood count (rule out myeloma, infection)
  • Comprehensive metabolic panel (calcium, phosphate, albumin, alkaline phosphatase, creatinine, liver enzymes)
  • 25-hydroxyvitamin D level
  • Intact parathyroid hormone (PTH)
  • 24-hour urine collection for calcium, sodium, creatinine (after vitamin D repletion and adequate calcium intake for 2 weeks)

Additional tests if indicated:

  • Thyroid-stimulating hormone (if on thyroid replacement or symptoms of hyperthyroidism)
  • Tissue transglutaminase antibodies (celiac disease screening)
  • Serum protein electrophoresis with free kappa/lambda light chains (myeloma screening, especially if anemia, hypercalcemia, or renal dysfunction)
  • Bone turnover markers (optional, not routinely required)

Bone mineral density (BMD) testing:

  • Dual-energy X-ray absorptiometry (DXA) of lumbar spine, hip, and forearm
  • T-score ≤ -2.5 confirms osteoporosis; however, the presence of fragility fracture alone establishes the diagnosis of osteoporosis regardless of BMD 2

Anatomic Basis for Signs and Symptoms

Pain mechanism:

  • Acute fracture causes periosteal disruption and trabecular microfractures, activating nociceptors
  • Pain worsens with movement because mechanical stress on fractured vertebrae increases
  • Deep breathing and Valsalva maneuvers increase intra-abdominal and intrathoracic pressure, transmitting forces to the spine
  • Paraspinal muscle spasm develops as a protective mechanism, contributing to pain

Height loss:

  • Progressive vertebral body collapse reduces anterior vertebral height
  • Multiple compression fractures compound the effect (each fracture can cause 1-2 cm height loss)
  • The 2-inch (5 cm) loss suggests multiple thoracic fractures over time

Kyphosis (forward stooped posture):

  • Wedge-shaped vertebral deformities (anterior height < posterior height) create forward angulation
  • Multiple adjacent wedge fractures produce cumulative kyphotic deformity
  • Increased kyphosis shifts the center of gravity anteriorly, creating a positive feedback loop that increases anterior vertebral loading and fracture risk 4

Respiratory compromise (elevated RR):

  • Thoracic kyphosis reduces chest wall compliance and lung volumes
  • Restrictive pulmonary pattern develops with severe kyphosis
  • Pain with deep breathing causes splinting and shallow respirations

Functional decline:

  • Kyphosis impairs balance and increases fall risk
  • Chronic pain limits mobility, leading to muscle atrophy and deconditioning
  • Loss of independence in activities of daily living

Clinical Impression and Differential Diagnosis

Primary diagnosis: Multiple osteoporotic vertebral compression fractures with thoracic kyphosis

This is supported by 2, 1, 6:

  • Classic demographic (postmenopausal woman, age 72)
  • Characteristic pain pattern
  • Significant height loss (>1.5 inches)
  • Kyphotic deformity
  • Prior osteoporosis treatment
  • Absence of "red flags" for malignancy or infection

Differential considerations to exclude:

  1. Pathological fractures from metastatic disease (breast, lung, kidney, thyroid, prostate in men)

    • Would expect constitutional symptoms, more severe/progressive pain, possible neurological deficits
    • MRI would show soft tissue masses, pedicle involvement
    • Requires biopsy if suspected
  2. Multiple myeloma

    • Screen with CBC (anemia), serum protein electrophoresis, free light chains
    • Hypercalcemia, renal dysfunction, lytic lesions on imaging
  3. Osteomalacia (vitamin D deficiency)

    • Would show low 25(OH)D, elevated PTH, low/normal calcium, elevated alkaline phosphatase
    • Pseudofractures (Looser zones) on imaging
  4. Chronic vertebral osteomyelitis/discitis

    • Would expect fever, elevated inflammatory markers
    • MRI shows disc space involvement, endplate destruction, epidural abscess
  5. Paget's disease

    • Markedly elevated alkaline phosphatase
    • Characteristic "picture frame" vertebrae on radiographs

Complications of Untreated Osteoporotic VCFs

Progressive skeletal complications:

  • Additional vertebral fractures: Each VCF increases the risk of subsequent fractures 5-fold 7
  • Progressive kyphosis: Leads to "dowager's hump" deformity
  • Height loss: Can exceed 4-6 inches with multiple fractures
  • Spinal instability: Rarely, but can occur with severe collapse

Pulmonary complications:

  • Restrictive lung disease: Severe kyphosis reduces lung capacity
  • Pneumonia: Decreased chest wall mobility and impaired cough
  • Respiratory failure: In extreme cases with severe thoracic deformity

Functional and quality of life impacts:

  • Chronic pain syndrome: Approximately 20% develop persistent pain 3
  • Immobility and deconditioning: Leads to muscle atrophy, cardiovascular deconditioning
  • Increased fall risk: From altered center of gravity and impaired balance
  • Hip fractures: Immobility and continued bone loss increase risk
  • Loss of independence: Impaired activities of daily living
  • Pressure ulcers: From prolonged bed rest

Systemic complications:

  • Deep venous thrombosis/pulmonary embolism: From immobility
  • Depression and social isolation: From chronic pain and disability
  • Increased mortality: VCFs are associated with 23-34% increased mortality risk, particularly in the first year after fracture 7
  • Gastrointestinal symptoms: Severe kyphosis can cause early satiety, reflux, constipation from abdominal compression

Cascade effect:

  • Immobility accelerates bone loss, creating a vicious cycle
  • Each fracture increases biomechanical stress on adjacent vertebrae 4
  • Progressive deformity worsens all complications

Management Approach

Immediate management:

Conservative treatment is first-line for acute VCFs 3, 1, 7:

  • Analgesics: Acetaminophen, NSAIDs (with gastroprotection in elderly), short-term opioids if needed
  • Calcitonin (nasal or subcutaneous) for acute pain relief in first 2-4 weeks
  • Limited bed rest (minimize to prevent deconditioning)
  • Physical therapy once acute pain subsides
  • Bracing has limited evidence but may provide short-term support

Vertebral augmentation consideration:

If pain persists beyond 6 weeks despite conservative management, consider vertebroplasty or kyphoplasty 3, 8. Evidence shows:

  • Optimal timing is 3-6 weeks after fracture onset 8
  • Kyphoplasty may be preferred over vertebroplasty for patients with severe kyphotic deformity, as it better restores vertebral height and has lower risk of adjacent fractures 9, 8
  • Vertebroplasty is more cost-effective and accessible for patients without severe deformity 8

Long-term osteoporosis management (critical to prevent future fractures):

Initiate anti-osteoporotic pharmacotherapy 2:

  • Bisphosphonates (alendronate, risedronate, zoledronic acid) are first-line
  • Denosumab for patients intolerant to bisphosphonates or with renal impairment
  • Anabolic agents (teriparatide, abaloparatide, romosozumab) for very high-risk patients with multiple fractures or very low BMD
  • After anabolic therapy, transition to anti-resorptive agent to maintain gains 2

Ensure adequate calcium (1,000-1,200 mg/day) and vitamin D (800-1,000 IU/day, titrate to 25(OH)D >30 ng/mL)

Referral indications:

Consider referral to endocrinology or osteoporosis specialist for 2:

  • Recurrent fractures despite treatment
  • Unexplained fractures with normal BMD
  • Young age or unusual features
  • Secondary causes requiring specialized management
  • Renal impairment complicating medication choices

Surgical consultation is reserved for 3, 10:

  • Neurological deficits
  • Spinal instability
  • Severe progressive deformity unresponsive to conservative measures

The key to this patient's management is confirming the diagnosis with imaging, excluding secondary causes with laboratory testing, initiating appropriate osteoporosis pharmacotherapy to prevent future fractures, and considering vertebral augmentation if conservative pain management fails by 6 weeks 2, 3, 8.

References

Research

Vertebral Compression Fractures.

American family physician, 2026

Guideline

american association of clinical endocrinologists/american college of endocrinology clinical practice guidelines for the diagnosis and treatment of postmenopausal osteoporosis-2020 update.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologist, 2020

Research

The effect of thoracic kyphosis and sagittal plane alignment on vertebral compressive loading.

Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 2012

Research

Diagnosis and Management of Vertebral Compression Fracture.

The American journal of medicine, 2022

Research

Diagnosis and Management of Osteoporotic Vertebral Compression Fractures.

The Journal of bone and joint surgery. American volume, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.